Royal Bank of Canada’s InMed Pharmaceuticals INM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24
| Closed | – | – | 6503 |
|
|
2024
Q3 | $0 | Sell |
24
-1
| -4% | – | ﹤0.01% | 6613 |
|
|
2024
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 6817 |
|
|
2024
Q1 | $0 | Buy |
25
+14
| +127% | – | ﹤0.01% | 6728 |
|
|
2023
Q4 | $0 | Sell |
11
-15
| -58% | – | ﹤0.01% | 6740 |
|
|
2023
Q3 | $0 | Buy |
26
+8
| +44% | – | ﹤0.01% | 6763 |
|
|
2023
Q2 | $0 | Buy |
18
+7
| +64% | – | ﹤0.01% | 6920 |
|
|
2023
Q1 | $0 | Hold |
11
| – | – | ﹤0.01% | 6784 |
|
|
2022
Q4 | $0 | Buy |
11
+2
| +22% | – | ﹤0.01% | 6923 |
|
|
2022
Q3 | $0 | Sell |
9
-241
| -96% | – | ﹤0.01% | 7087 |
|
|
2022
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 6997 |
|
|
2022
Q1 | $0 | Sell |
250
-151
| -38% | – | ﹤0.01% | 7307 |
|
|
2021
Q4 | $1K | Buy |
401
+151
| +60% | +$377 | ﹤0.01% | 6967 |
|
|
2021
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 7157 |
|
|
2021
Q2 | $1K | Sell |
250
-336
| -57% | -$1.34K | ﹤0.01% | 6805 |
|
|
2021
Q1 | $2K | Buy |
586
+344
| +142% | +$1.17K | ﹤0.01% | 6734 |
|
|
2020
Q4 | $1K | Buy |
+242
| New | +$1K | ﹤0.01% | 6386 |
|